Skin Tech Pharma Group
Skin Tech Pharma Group is a Spain-based private medical aesthetics company that manufactures CE-marked hyaluronic-acid injectables, biorevitalization cocktails, chemical peelings, and cosmeceuticals, selling through authorized distributors to licensed practitioners in 80+ countries.
- Company typePrivate
- Founded1996
- HeadquartersCastelló, Spain
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Skin Tech Pharma Group does
Skin Tech Pharma Group S.L.U. is a Spain-headquartered private medical aesthetics company founded in 1996 by Dr. Philippe Deprez. It develops, manufactures, and distributes a diversified portfolio of CE-marked aesthetic products organized into injectables (RRS HA Long Lasting, Hyalift 75, HA Cellutrix, HA Eyes, HA Injectable, XL Hair), chemical peelings, transdermal biorevitalization cocktails (Reparestim line), mesotherapy solutions (Mesocare), intimate-care cosmeceuticals (HAPPY intim), sun protection (Melablock HSP), and professional at-home skincare (Peel2Glow, Atrofillin). Its underlying technology rests on hyaluronic-acid-based dermal implants combined with a proprietary Protective Buffer Technology that stabilizes HA alongside vitamins, antioxidants, micro-circulatory actives, and blending/bleaching agents, supplemented by synthetic peptide platforms such as BoNtA 568.
The company operates a B2B distribution model selling exclusively through authorized distributors and licensed aesthetic practitioners (physicians, dermatologists, plastic surgeons, medical spas) across more than 80 countries, with manufacturing to ISO 13485:2018 (since 2011), ISO 22716:2007, and CE Class III sterile-injectable standards. Revenue streams include one-time product sales across the injectable, cosmeceutical, peeling, and biorevitalization categories, contract development and manufacturing (CDMO) services for third-party aesthetic brands using Skin Tech's regulatory and formulation capabilities, and professional education and training fees via Skin Tech Academy, Medinet, and Distrinet digital platforms.
In June 2024, London-based Charterhouse Capital Partners made a strategic private equity investment with founder Dr. Philippe Deprez reinvesting alongside, with the stated purpose of funding organic growth, new market entry, product innovation, and acquisitions. The flagship RRS HA Long Lasting injectable, launched in 2021, has been used in over one million treatments worldwide and received the Best Injectable in Skin Revitalization award at AMWC 2026 in Barcelona.
Skin Tech Pharma Group firmographics
Firmographics- Name
- Skin Tech Pharma Group
- Legal name
- SKIN TECH PHARMA GROUP, S.L.U.
- Website
- https://skintechpharmagroup.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Skin Tech Pharma Group is a Spain-based private medical aesthetics company that manufactures CE-marked hyaluronic-acid injectables, biorevitalization cocktails, chemical peelings, and cosmeceuticals, selling through authorized distributors to licensed practitioners in 80+ countries.
- Ownership category
- akta.pro rank
Skin Tech Pharma Group industry classification
Industry- Product category
- Medical Aesthetics Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (3391), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
- akta.pro secondary industries
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK)
Keywords
Where Skin Tech Pharma Group is headquartered
LocationHeadquarters
- HQ city
- Castelló
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Skin Tech Pharma Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales (Injectables): Sale of CE Class III injectable medical devices including hyaluronic acid-based dermal implants, skin boosters, and specialty injectables for face, body, hair, and intimate areas.
- Cosmeceutical Products: Sale of professional skincare and cosmetic products including post-treatment serums, sun protection, anti-aging creams, and intimate care products.
- CDMO Contract Manufacturing Services: Contract development and manufacturing services for aesthetic medical devices and advanced skincare, including formulation, regulatory support, packaging design, and logistics.
- Education and Training Services: Skin Tech Academy provides courses, workshops, congresses, and webinars for aesthetic professionals. More than 500 courses and 2,000 members from 85 countries within 20 years.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | B2B pricing through distributor network - not publicly disclosed |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Skin Tech Pharma Group product offering
Product offeringCore offering
Skin Tech Pharma Group manufactures and globally distributes CE Class III hyaluronic acid-based injectable medical devices (RRS line including HA Long Lasting, Hyalift 75, HA Eyes, HA Cellutrix), transdermal biorevitalization cocktails (Reparestim), mesotherapy solutions (Mesocare), chemical peelings, and cosmeceutical skincare products to licensed aesthetic practitioners in over 80 countries. The company also provides CDMO contract manufacturing services for aesthetic medical devices and runs the Skin Tech Academy education platform.
Product overview
Skin Tech Pharma Group is a global medical aesthetics company based in Spain specializing in hyaluronic acid-based injectables and cosmetic products. The portfolio consists of injectable dermal implants (RRS line including HA Long Lasting, Hyalift 75, HA Cellutrix, HA Eyes, HA Injectable, and XL Hair), transdermal cocktail biorevitalization products (Reparestim line), mesocare solutions, and an extensive cosmeceutical line including RRS HA Long Lasting serums, Skin Tech branded products, HAPPY intim intimate care, and Peel2Glow professional treatments. The company operates digital platforms (Medinet for professionals, Distrinet for distributors), offers education through Skin Tech Academy, and provides CDMO contract manufacturing services. Products are sold in over 80 countries with CE certifications.
Differentiator
Problem solved
Functional benefit
Brands
- RRS®: Flagship brand of injectable dermal implants and aesthetic products including RRS® HA Long Lasting, RRS® Hyalift® 75, RRS® HA Eyes, RRS® HA Cellutrix, RRS® HA Injectable, and XL Hair®
- Aesthetic Dermal
- Happy intim®
- Benebellum
- Sagoni
- Peel2Glow
- Mesocare®
- Skin Tech Academy
Products and services
- RRS HA Long Lasting Flagship CE Class III injectable dermal implant for skin revitalization that combines characteristics of skin boosters and dermal fillers in a single treatment approach. Used in over one million treatments worldwide since its 2021 launch. Targeted at licensed aesthetic practitioners performing facial rejuvenation.
- RRS Hyalift 75 Non-cross-linked hyaluronic acid dermal implant indicated for skin photo-ageing, dermal atrophy treatment, and skin rejuvenation. For licensed aesthetic practitioners.
- RRS Hyalift 75 PROactive Non-cross-linked hyaluronic acid dermal implant with a protective buffer solution containing amino acids, delivering hydration and antioxidant properties for skin revitalization in clinical aesthetic settings.
- RRS HA Cellutrix Dermal implant formulated to soften edemato-fibrosclerotic panniculopathy (orange skin), with a protective buffer that includes antioxidants, flavonoids, and caffeine. For licensed practitioners treating body contour irregularities.
- RRS HA Eyes Intradermal implant for the eye contour area, reducing swelling and enhancing skin elasticity through resorbable hyaluronic acid combined with the proprietary protective buffer. Used by aesthetic practitioners for periorbital rejuvenation.
- RRS HA Injectable Complex injectable formula combining 72 active ingredients with non-cross-linked hyaluronic acid for anti-ageing treatment of the face, neck, hands, and body. Targeted at practitioners delivering full-face and body revitalization protocols.
- XL Hair Hair restoration injectable based on hyaluronic acid with a protective buffer containing FGF, GM peptide, and amino acids, designed to support papilla cell proliferation and stimulate hair growth in alopecia and pattern baldness cases. For licensed practitioners.
- Reparestim HA TD Anti-aging transdermal cocktail that regenerates aged, oxidized, and mature skin through antioxidant action and enhanced skin elasticity. For aesthetic practitioners performing biorevitalization protocols.
- Reparestim Eyes TD Eye contour transdermal cocktail with a whitening effect for congested and tired skin, reducing swollen eyes and improving skin elasticity. Used by aesthetic practitioners for periorbital biorevitalization.
- Reparestim Relax Skin TD Peptide-based transdermal cocktail leveraging BoNtA 568® synthetic oligopeptides (Pentapeptide-18, Acetyl Hexapeptide-8, Acetyl Octapeptide-3) to soften expression wrinkles on the face and décolletage. For licensed practitioners offering peptide biorevitalization treatments.
- Reparestim Whitening TD Transdermal lightening solution for hyperpigmentation disorders with whitening and antioxidant properties suitable for all skin photo types. Used by practitioners treating pigmentation irregularities.
- Reparestim Cellulite TD Transdermal skin tone enhancer for orange skin, dehydration, thin skin, and hormonal changes, providing firming and anti-radical effects in body biorevitalization protocols.
- Reparestim Stretch 360 TD Transdermal mesosolution that improves elasticity and skin thickness in stretch mark areas through firming and antioxidant action. For practitioners treating stretch marks and related skin texture concerns.
- Reparestim Hair TD Capillary regenerator combining hyaluronic acid and biotin to revitalize and strengthen hair fibre for both men and women. For licensed practitioners offering hair restoration protocols.
- TX Solution Spot remover formulated with tranexamic acid and polyphenols to treat localized skin marks, unify tone, and brighten skin. For aesthetic practitioners performing localized pigmentation interventions.
- Mesocare Solutions Complete range of monodose sterile mesotherapy solutions with concentrated single active ingredients, including HYALIFT 3.5, Xadenal, DM-Lift, Silorgamine, and Centellasial. For licensed practitioners performing mesotherapy biorevitalization.
- RRS HA Long Lasting AM Serum Daytime dermastructurer serum designed for post-treatment skin care following RRS HA Long Lasting injectable procedures. Sold through licensed aesthetic clinics for patient home use as a cosmeceutical adjunct.
- RRS HA Long Lasting PM Serum Night collagen builder serum for post-treatment recovery and skin rejuvenation, complementing the RRS HA Long Lasting injectable protocol. Sold through licensed clinics for patient home use.
- IPLase Mask Post-treatment cream formulated to reduce skin stress caused by laser, IPL, UV radiation, and other thermal or energy-based procedures. Sold through licensed clinics for patient home use.
- Melablock-HSP SPF 50 4-in-1 sun protection providing UVA, UVB, IR, and Blue Light defense combined with Heat Shock Protein activation for thermal ageing protection. Sold through licensed clinics as a post-procedure cosmeceutical.
- Atrofillin Skin volumizer and anti-aging cream with dual action that clarifies and unifies the skin while improving dermal thickness quality. Sold through licensed clinics for patient home use.
- HAPPY intim Line Intimate beauty product line for aesthetic practitioners and clinics, including Lightening Cream, Rebirth Cream, Body Peel, Body Butter, Nebula, Satin, and Velagel for intimate skin care.
- Peel2Glow Line Professional-grade enzymatic peel and glow line including Refine & Allure, Bio & Active, Purifyer, Hydrabionic, Micellar Water, Neosolex Mist, and Ultra creams, supplied to clinics for in-clinic use and recommended for at-home aesthetic regimens.
- Medinet Professional Platform Exclusive digital platform for licensed aesthetic practitioners providing structured access to premium product education, clinical protocols, treatment guidance, and internationally recognized webinars. Supports practitioner onboarding and continued clinical training.
- Distrinet Distributor Portal B2B portal for authorized distributors and partners providing product information, marketing materials, training resources, and ordering tools in support of Skin Tech Pharma Group's global distribution network.
- Skin Tech Academy Multidisciplinary aesthetic medicine education school delivering courses, workshops, congresses, and webinars, with more than 500 events and 2,000 members across 85 countries over 20 years. Offered to licensed aesthetic professionals in partnership with Medical Universities and Medical Societies.
- CDMO Services Contract development and manufacturing services for aesthetic medical devices and advanced skincare, covering product formulation, regulatory support, packaging design, stability and efficacy studies, storage, and logistics under the company's ISO 13485:2018 and ISO 22716:2007 (GMPc) quality system. Targeted at third-party aesthetic and skincare brands seeking outsourced manufacturing.
Quantifiable outcome
- Over 1 million treatments performed with RRS® HA LONG LASTING since 2021 launch
- +2 more outcomes
Companies that use Skin Tech Pharma Group
Customer profileSegments3 records
Ideal customer profiles3 records
Skin Tech Pharma Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Skin Tech Pharma Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Medical Universities and Medical SocietiescorePartnerships established with Medical Universities and Medical Societies that allowed Skin Tech Academy to be part of international congress as a recognized scientific reference. Over 20 years of collaborative education initiatives.
- Dr. Philippe DeprezcoreCompany founder Dr. Philippe Deprez reinvested in the transaction alongside Charterhouse Capital Partners, maintaining his role and commitment to the company's growth strategy.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Skin Tech Pharma Group competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Skin Tech Pharma Group social profiles
Digital presenceSkin Tech Pharma Group compliance and trust
Trust signalCompliance6 records
Skin Tech Pharma Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Skin Tech Pharma Group leadership team
Management profileNumber of profiles
Profiles2 records
Skin Tech Pharma Group funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Skin Tech Pharma Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Skin Tech Pharma Group
What does Skin Tech Pharma Group do?
Skin Tech Pharma Group manufactures and globally distributes CE Class III hyaluronic acid-based injectable medical devices (RRS line including HA Long Lasting, Hyalift 75, HA Eyes, HA Cellutrix), transdermal biorevitalization cocktails (Reparestim), mesotherapy solutions (Mesocare), chemical peelings, and cosmeceutical skincare products to licensed aesthetic practitioners in over 80 countries. The company also provides CDMO contract manufacturing services for aesthetic medical devices and runs the Skin Tech Academy education platform.
Is Skin Tech Pharma Group a public or private company?
Skin Tech Pharma Group is a private company. It is classified as private equity controlled and is currently operating.
When was Skin Tech Pharma Group founded?
Skin Tech Pharma Group was founded in 1996. It employs 101 to 250 people.
Where is Skin Tech Pharma Group based?
Skin Tech Pharma Group is headquartered in Castelló, Spain, in the Europe region.
How does Skin Tech Pharma Group make money?
Four revenue lines are on record. Medical Device Sales (Injectables) is the primary driver. The others are cosmeceutical Products, CDMO Contract Manufacturing Services and education and Training Services.
Does Skin Tech Pharma Group have an API?
No public API is recorded for Skin Tech Pharma Group.
What industry is Skin Tech Pharma Group in?
Skin Tech Pharma Group's product category is Medical Aesthetics Devices. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of HLAGABAG, Drug Substance–Drug Product Integrated CDMO. Its NAICS code is 339112 and its SIC code is 3841.